Share Name Share Symbol Market Type Share ISIN Share Description
Centrica LSE:CNA London Ordinary Share GB00B033F229 ORD 6 14/81P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.75p -0.49% 153.05p 5,607,156 08:42:09
Bid Price Offer Price High Price Low Price Open Price
153.00p 153.10p 153.15p 151.50p 152.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Gas Water & Utilities 28,023.00 142.00 6.00 25.5 8,635.3

Centrica (CNA) Latest News

More Centrica News
Centrica Takeover Rumours

Centrica (CNA) Share Charts

1 Year Centrica Chart

1 Year Centrica Chart

1 Month Centrica Chart

1 Month Centrica Chart

Intraday Centrica Chart

Intraday Centrica Chart

Centrica (CNA) Discussions and Chat

Centrica (CNA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:42:09153.059711,486.12AT
07:42:09153.051,5002,295.75AT
07:42:09153.05122186.72AT
07:42:09153.053,0004,591.50AT
07:42:01153.003,2004,896.00AT
View all Centrica trades in real-time

Centrica (CNA) Top Chat Posts

DateSubject
19/7/2018
09:20
Centrica Daily Update: Centrica is listed in the Gas Water & Utilities sector of the London Stock Exchange with ticker CNA. The last closing price for Centrica was 153.80p.
Centrica has a 4 week average price of - and a 12 week average price of 140.20p.
The 1 year high share price is 208.60p while the 1 year low share price is currently 123.10p.
There are currently 5,642,168,549 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Centrica is £8,581,738,363.03.
16/6/2018
11:59
garycook: Is the Centrica share price too cheap to ignore? Shares in British Gas owner Centrica (LSE: CNA) have been languishing in recent months, trailing sector peers such as SSE and National Grid. From hitting a peak of just over £4 in 2013, Centrica’s share price has since more than halved to 153p. Competitive pressure Investors clearly believe Centrica stands to lose out big time against the looming price cap on energy tariffs and ongoing competitive pressures in the retail supply business. That intense competition was partly behind the loss of another 110,000 domestic customer accounts in the first four months of the year, which came on top of a decline of roughly 1.3m customer accounts last year. With a haemorrhaging of its customer base, there are growing worries about the impact on the company’s long-term earnings ability, not least because of the uncertain sustainability of its dividend. Let’s not forget that Centrica has already taken an axe to its dividend before — only back in 2015, the group cut its dividend by 30% after profits fell sharply in the wake of a slump in oil and gas prices. Near-term tailwinds But despite the tough operating environment, the company still generates good cash flow and has a high level of financial flexibility, which is underpinned by its relatively stable balance sheet position. Also reassuringly, the company said it expects to be able to maintain the current 12p per share dividend in the current financial year. There are a number of near-term tailwinds to consider as well, including the improvement in commodity prices since the start of the year and a potential sale in its 20% stake in EDF Energy Nuclear Generation. Meanwhile earlier this week, City broker Jefferies upgraded Centrica to a ‘buy’ on expectations of a “more balanced approach” towards the impending introduction of the government’s energy price cap, following the release of Ofgem’s recent consultation paper which gave “detailed consideration of suppliers’ costs”. Sure, there’s still a great deal of uncertainty with the Centrica’s long-term earnings outlook, but I reckon more of the risk is now on the upside. Shares in the group trade at just 12.5 times its expected earnings this year and offer prospective investors a very high dividend yield of 7.8%.
06/6/2018
11:10
knowing: JP Morgan Cazenove today upgrades its investment rating on Centrica PLC (LON:CNA) to overweight (from neutral). Centrica PLC with EPIC/TICKER (LON:CNA) has had its stock rating noted as ‘Upgrades̵7; with the recommendation being set at ‘OVERWEIGHT217; today by analysts at JP Morgan Cazenove. Centrica PLC are listed in the Utilities sector within UK Main Market. JP Morgan Cazenove have set their target price at 180 GBX on its stock. This is indicating the analyst believes there is a potential upside of 23.2% from today’s opening price of 146.15 GBX. Over the last 30 and 90 trading days the company share price has decreased 7.5 points and increased 4.05 points respectively. The 1 year high for the stock price is 213 GBX while the year low share price is currently 123.1 GBX. Centrica PLC has a 50 day moving average of 147.43 GBX and a 200 Day Moving Average share price is recorded at 154.68. There are currently 5,694,095,105 shares in issue with the average daily volume traded being 30,236,861. Market capitalisation for LON:CNA is £8,259,285,124 GBP.
12/4/2018
09:40
careful: For long term investors I wonder if the share price matters at all. Warren Buffett said that in the early days he did not even allow computers in his offices. He did not want the share price checked on a regular basis, not important. Mr.market is irrational, but offers a good entry point if he gets the price wrong. All that really matters is cash flow, profit, dividends, assets and long term prospects. As far as CNA goes you have to feel sorry for investors who held the shares 2-3 years ago when the price was £4.0. Obviously they should have sold. The rest of us, especially those who bought below £2, should look away. This company could take years to re establish itself, maybe after the next election. The problem with CNA is that there are hundreds of alternative investments to compete with it. So there will be very little buying until the picture clears.
10/4/2018
13:09
garycook: Is £7.9 billion integrated energy group Centrica (CNA) shaping up as a genuine 'buy', or a superficial high-yield play with poor fundamentals? I drew attention last December at 138p following a drop from 160p after a 27 November update cited the loss of 823,000 UK energy accounts since end-June, plus intense competition in North America. Versus this bad news, a relatively new chief executive (BP's ex-head of refining) had added 100,000 shares at 145p, having also bought (with the chairman) at 173-175p in October. Cash flow strengths underlined the prospect of a 12p dividend, giving an 8.7% prospective yield. With Labour renationalisation threats a long-shot and oil & gas prices looking firm, "risk-tolerant contrarians should consider averaging into Centrica while more cautious investors will await chart confirmation of a low." So, where are we post-prelims and the price having thrice risen to 145p? Source: interactive investor Past performance is not a guide to future performance Near reverse head & shoulders chart pattern It's not exact but, since December, there's been a modest "first shoulder" followed by a decent "head" (if related to February's wider volatility), and now a "second shoulder" has completed. In principle that's a classic major reversal pattern, coming after a long drop from 350p in 2014. I wouldn't take that as a cue but, given behaviour patterns are apt to repeat, it's interesting to compare with the fundamentals as to whether Centrica is at a turning point. It would appear the flow of bad news is at least paused, and, if contained, then the group's challenges are most likely priced in, such that on a chart basis, even small positives can drive medium-term upside. 2017 prelims: cash flow guidance is key Cash flow is the vital element influencing whether a 12p per share payout is sustainable medium-term. Headlines from the 22 February results were poor, albeit priced into the stock anyway: adjusted operating profit down 17% to £1,252 million on 3% revenue growth, with adjusted earnings per share (EPS) down 25% to 12.6p and underlying adjusted operating cash flow down 13%. Exceptional charges make for a complexity of "underlying/adjusted" definitions, with adjusted operating cash flow declared at £2.1 billion, which compares with the £672 million cost of a 12p dividend. Yes, there are other demands on cash flow, but this strength helps explain why the board says it expects to maintain the payout until 2020 - so long as annual cash flow turns out at £2.1 billion to £2.3 billion and net debt stays in a £2.25-3.25 billion range. This is supported by a £750 million reduction in controllable costs to £4.5 billion in the last three years, with a further £500 million targeted by 2020. As regards to turning a supertanker, Centrica represents, it's a pretty good start, although the "new" chief executive has been in place since January 2015, hence the share price slump has probably done most to instil urgency. Centrica - financial summary year ended 31 Dec 2013 2014 2015 2016 2017 2018 Turnover (£ million) 26,571 29,408 27,971 27,102 28,023 IFRS3 pre-tax profit (£m) 1,649 -1,403 -1,136 2,186 142 Normalised pre-tax profit (£m) 2,707 405 1,231 2,259 872 1,030 Operating margin (%) 10.6 1.8 4.7 9.1 1.7 IFRS3 earnings/share (p) 18.3 -20.2 -14.9 31.2 6.0 Normalised earnings/share (p) 37.6 16.0 28.8 31.3 12.6 14.0 Earnings per share growth (%) 2.7 -57.4 79.8 9.0 Price/earnings multiple (x) 4.4 11.3 10.2 Historic annual average P/E (x) 8.5 16.1 7.6 6.5 4.3 Cash flow/share (p) 56.6 21.8 42.0 45.1 Capex/share (p) 31.0 28.7 19.2 15.3 Dividend per share (p) 16.7 17.2 12.0 12.0 12.0 12.0 Dividend yield (%) 8.4 8.4 Covered by earnings (x) 2.3 0.9 2.4 2.6 1.1 1.2 Net tangible assets per share (p) 9.2 -37.5 -52.2 -31.3 -16.0 Source: Company REFS Past performance is not a guide to future performance Uncertainties remain for both key divisions Energy supply/services to consumers and business are Centrica's backbone, about 80% of group revenue/profit, with energy trading at about 10% and down due to legacy gas contracts, the other activities performing mixed. Last December, I defined the key challenge as figuring out what will be the net effect of Ofgem extending price caps, and whether British Gas's energy marketing can improve. On 6 March Ofgem confirmed that in response to February's government proposals for a cap on Standard Variable Tariffs (SVT's) it declared its intention to cap prices to end-2023 unless the Secretary of State decides otherwise. Stockwatch: A 9% yield for contrarians Centrica and other energy suppliers argue that evidence abroad shows this will mean less competition with prices clustering around the cap; and British Gas already claims to be 85% cheaper than other SVT's, though last November withdrawing SVT for new customers as if affirming a negative. So, it remains uncertain how this will pan out; the extent British Gas can achieve margin growth like it says, with new customer offers. Meanwhile, Ofgem has already capped pre-payments on energy meters, a move that tightened last October and is partly why Centrica Consumer declared effectively flat operating profit: the effects of warmer weather, competition and a UK prepayment cap offset by cost efficiencies. Again, it remains to be seen if further cost cutting offsets the SVT price cap. Meanwhile, operating profit for Centrica Business has plunged 67% to £161 million due to competition eroding margins, and warmer weather, both for the UK and US. Management says it is addressing margins and anticipates "good growth prospects" in the US, though investors may await the evidence. The narrative should also be counter-balanced e.g. the next update on 14 May, by recent cold weather benefiting energy suppliers. Potential for step-change reduction in gearing End-2017 net debt fell 25% to £2.6 billion, although, with the Bank of England hinting at interest rate rises, this extent of debt has likely contributed to the stock's fall. The results indicated "no plans for any major M&A" alongside "intent to pursue sale of UK nuclear investment", which is interesting after Centrica bought a 20% stake in the nuclear fleet of eight power stations for £2.4 billion late in 2009. While there are very few buyers of nuclear assets acceptable to the government and EDF (which bought them from British Energy earlier in 2009) this would transform Centrica's balance sheet and perception of dividend risk - even lend the prospect of a special dividend. It's a speculation, albeit with good grounds, a straightforward payback representing over 30% of present market cap. The share price would likely rise with holders having locked in an 8%-plus yield. Lack of material short-selling Only 0.58% of Centrica's equity is out on loan, to AQR Capital Management, which represents the entire disclosed short positions - AQR being quite a prolific shorter of UK equities. The upshot is mixed: while there's no shorting party underway liable to hit the price in response to bad news, equally there's no coiled spring as exists in "most shorted" stocks that need buying back in the market. Thus, Centrica has fallen about 60% for industry-specific reasons, not manipulation, and hedge funds don't regard it as being in a compellingly weak position. SSE (SSE) has similarly had about 0.5% of its stock on loan, now reduced to zero disclosed. Clouds therefore remain, albeit silver linings Trying to avoid confirmation bias, this update concludes net-positively: the extent of bad news is well-manifest, with scope for it to improve overall. Operationally that assumes trusting management can deliver on further cost reductions and marketing gains, like it says. Much remains to overcome, but that's why the stock offers an 8%-plus yield. Take your own view of the risks, but given the chance the 12p dividend is supported by cash flow, there's scope to get lucky. The stock may next take its cue from the 14 May update, which can hardly warn about weather. Speculative buy.
12/3/2018
07:51
capeview: One thing that could make for interesting times, if more mergers or acquisitions happen in this sector and CNA is left on the side line until near the end, it could either mean not a great share price for the buy as no one left to fight for them but it keeps on keeping on, or the other way to look at it, there could be enough players out there that want to get into the sector meaning people fall over themselves to snap up CNA causing the share price to rocket, because it's the only decent player left in the game. I vote for the latter. :) In the mean time I vote for the share price increasing and keeping the dividend going. But also, it could be bought up sooner and being the player it is, it could even have a bunch of players snapping at it's heals.
11/3/2018
13:38
whatsup32: This sector is getting more and more ‘merger and acquisition’ news . In the coming weeks this should reflect in the CNA share price . CNA market value at fridays close £7.94 billion . Pocket change to some in the continent:)
02/1/2018
16:01
selborne_edge: At the risk of jumping to conclusions, it begins to look as if the tide has turned on the CNA share price. Wall Street is doing well and that is a very good sign.
28/11/2017
22:17
supermarky: As for Centrica (CNA), we have a massive argument demanding it bounce from 136p. Or at least, we had, prior to the market opting to gap the share price down to our supposed "bottom" level the other day.When a share price illustrates this sort of manipulation, we always regard is as the opening salvo of a new trend developing and, as it was forced down, it's unlikely such a trend shall be upward.The immediate situation is a little awkward with the price requiring better than 149.5p to give a clue of a bottom being "in" and some moves toward 156p can commence.While this comes close to covering the manipulation gap, ideally we'd demand the share price better the light blue line on the chart below, the prior downtrend currently at 165p, before daring make the assumption the market has made a dreadful mistake and intends correct the error. Who knows, perhaps some bright spark will come along with a good idea.In our experience, this isn't going to happen without game changing news.More likely, it now appears any weakness below 133p risks a continued drop cycle toward 102p with some bounce potential. The severe (and stupid sounding) secondary calculates at 66p. This is a point where we'd hope some real recovery to commence.Finally, the share price requires exceed dark blue, currently 197p, for hope of generating some proper upward travel.
24/11/2017
16:29
careful: something wrong with my computer. What is that strange blue number in my CNA share price movement column. it has always been red in the past.
07/11/2017
10:06
careful: Power supply, gas, oil, services. No reason why CNA shouldn't be rerated upwards. In all of the right sectors, politics aside. We have some companies like Tesla and Amazon making no money at all with a negligible prospect of paying dividends. Their share are stupidly overvalued. Then we have CNA, stupidly cheap by most measures. If CNA share price doubled it would still not be expensive. Crazy times driven by momentum and algo trading. It creates ludicrous prices in both directions.
Centrica share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180719 07:57:13